NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial
Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted
FDA Approves Initiation of a New Trial in Recurrent Glioblastoma